Literature DB >> 6087337

Influence of the beta-adrenergic receptor concentration on functional coupling to the adenylate cyclase system.

Y Severne, D Coppens, S Bottari, M Riviere, R Kram, G Vauquelin.   

Abstract

Only part of the beta-adrenergic receptors can undergo functional coupling to the adenylate cyclase regulatory unit. This receptor subpopulation shows an increased affinity for agonists in the presence of Mg2+ and undergoes rapid "inactivation" (locking-in of the agonist) by the alkylating reagent N-ethylmaleimide in the presence of agonists. Several experimental conditions, known to modify the total receptor concentration without alteration of the other components of the adenylate cyclase system, do not affect the percentage of receptors that can undergo functional coupling: (i) homologous regulation of beta 1 receptors in rat brain by noradrenaline (through antidepressive drug or reserpine injections); (ii) up- and down-regulation of the beta 2 receptors in Friend erythroleukemia cells by, respectively, sodium butyrate and cinnarizine treatment; and (iii) dithiothreitol-mediated inactivation of receptors in turkey erythrocytes, Friend erythroleukemia cells, and rat brain. Our findings argue against a stoichiometric limitation in the number of regulatory components, genetically different receptor subpopulations, bound guanine nucleotides, or reduced accessibility of part of the receptors to the agonists as the cause for functional receptor heterogeneity. Differences in either the receptor conformation or its membrane microenvironment are more plausible explanations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087337      PMCID: PMC391545          DOI: 10.1073/pnas.81.15.4637

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Evidence for essential disulfide bonds in beta1-adrenergic receptors of turkey erythrocyte membranes. Inactivation by dithiothreitol.

Authors:  G Vauquelin; S Bottari; L Kanarek; A D Strosberg
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

2.  The agonist-specific effect of magnesium ion on binding by beta-adrenergic receptors in S49 lymphoma cells. Interaction of GTP and magnesium in adenylate cyclase activation.

Authors:  S J Bird; M E Maguire
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

3.  Altered responsiveness of cerebral beta adrenoceptors assessed by adenosine cyclic 3',5'-monophosphate formation and (3H)propranolol binding.

Authors:  S R Nahorski
Journal:  Mol Pharmacol       Date:  1977-07       Impact factor: 4.436

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Chemical modification of the beta adrenergic receptors coupled with adenylate cyclase by disulfide bridge-reducing agents.

Authors:  M Lucas; J Hanoune; J Bockaert
Journal:  Mol Pharmacol       Date:  1978-03       Impact factor: 4.436

6.  Selective alteration in high affinity agonist binding: a mechanism of beta-adrenergic receptor desensitization.

Authors:  M R Wessels; D Mullikin; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

7.  Isolation and characterization of S49 lymphoma cells deficient in beta-adrenergic receptors: relation of receptor number to activation of adenylate cyclase.

Authors:  G L Johnson; H R Bourne; M K Gleason; P Coffino; P A Insel; K L Melmon
Journal:  Mol Pharmacol       Date:  1979-01       Impact factor: 4.436

8.  Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.

Authors:  G A Weiland; K P Minneman; P B Molinoff
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

9.  Agonist-induced increase in apparent beta-adrenergic receptor size.

Authors:  L E Limbird; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

10.  Effect of nerve degeneration by 6-hydroxydopamine on catecholamine-stimulated adenosine 3',5'-monophosphate formation in rat cerebral cortex.

Authors:  A Kalisker; C O Rutledge; J P Perkins
Journal:  Mol Pharmacol       Date:  1973-09       Impact factor: 4.436

View more
  3 in total

1.  Agonist-mediated conformational changes of beta-adrenoceptors could occur independent of functional coupling to Ns.

Authors:  Y Severne; L Kanarek; G Vauquelin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

Review 2.  Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.

Authors:  Georges Vauquelin; Sophie Bostoen; Patrick Vanderheyden; Philip Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-14       Impact factor: 3.000

Review 3.  Embryonal central neuroepithelial tumors: current concepts and future challenges.

Authors:  S R Vandenberg; M M Herman; L J Rubinstein
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.